Manage episode 277831068 series 2813433
In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership talks to Christian Hogg, Executive Director and CEO of Chi-Med, about how the pharmaceutical and biotech industry in China has shifted its priorities from generic medicines to more innovative therapies. Christian talks in depth around the driving factors and investment in innovation, including a reform of the regulatory environment and the vast expansion of access to patients. He also gives his take on why he believes some multi-national companies prosper, and why some fail, when trying to enter the Chinese biotech and pharmaceutical markets, and what they can do to make the most of the growing opportunities within this market. They finish by discussing the possibility that one day China will overtake the US to become the biggest pharmaceutical market in the world.